Nutlin3, an early prototype inhibitor of p53-MDM2 interaction, was shown to synergize with vemurafenib in inducing cell death in melanoma cell lines and inhibiting tumor growth in vivo [128]. The gene discussed is MDM2; the disease is neoplasm.